Medicines NZ

Medsafe group manager Chris James explains how the process for classifying medicines works in New Zealand

Pseudoephedrine-based cold and flu medications can now be purchased from pharmacists

The new Government began the process of repealing the Therapeutic Products Act last month, but pharmaceutical sector leaders say they are still in the dark about what will replace it.

Associate health minister Casey Costello is seeking approval from Cabinet to repeal the Therapeutic Products Act this week 

The delisting date for cilazapril has been pushed out to mid2024, Pharmac reports.

Medicines New Zealand says political parties’ pre-election pledges to increase Pharmac’s funding are positive, but much more will be needed if the next government wants to clear the backlog of unfunded medicines

The publication of drug companies’ payments to doctors is a boon for transparency and for patients’ understanding of the relationship between the industry and their healthcare professional, says Medicines New Zealand

After a four-year hiatus, Medicines New Zealand has relaunched its annual Value of Medicines award, this time adding a new award for young scientists worth $30,000

Opposition health spokesperson Michael Woodhouse claims health minister David Clark has used creative accounting to make old funding seem new, while injecting little into the drug-funding agency’s now billion-dollar annual budget 

Rumours of the cough syrup Gees Linctus disappearing from the New Zealand market have been greatly exaggerated, despite the popular medicine becoming restricted to prescription only